Source: Annual Congress 2006 - Respiratory diseases in primary care
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Price, S. V. Morant, R. Horne, D. Pettitt, T. MacDonald (Aberdeen, Haddendum, Brighton, Dundee, United Kingdom; New York, United States Of America). Determinants of long acting bronchodilator adherence in UK COPD patients. Eur Respir J 2006; 28: Suppl. 50, 3613

Member's Comments

No comment yet.

Related content which might interest you: Lung function, symptoms and prescription of inhaled steroids and long acting β2 agonists in patients managed by an integrated COPD team Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Characteristics of patients newly prescribed a long acting bronchodilator in the US Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease Year: 2013 Adherence of stable COPD patients to inhaled pharmacotherapy Source: Annual Congress 2011 - COPD management Year: 2011 The influence of type of inhalation device on adherence of COPD patients to inhaled medication Source: Annual Congress 2013 –COPD drugs: new findings Year: 2013 The bronchodilator response to salmeterol is maintained with regular, long-term use in patients with COPD Source: Eur Respir J 2002; 20: Suppl. 38, 240s Year: 2002 The impact of stepwise withdrawal of inhaled corticosteroids on lung function in COPD patients receiving dual bronchodilation: WISDOM study Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 The adherence to inhaled drugs in COPD patients: Effect on survival Source: International Congress 2015 – Treatment and control of respiratory disease Year: 2015 The impact of stepwise withdrawal of inhaled corticosteroids on exacerbations in COPD patients receiving dual bronchodilation: WISDOM study Source: International Congress 2014 – Bronchodilators for asthma and COPD Year: 2014 Use of long acting bronchodilators and inhaled corticosteroids within 30-days of discharge in older adults hospitalized for AECOPD Source: International Congress 2015 – Treatment and control of respiratory disease Year: 2015 Differences in adherence to common inhaled medications in COPD Source: Annual Congress 2013 –COPD drugs: new findings Year: 2013 Assessing bronchodilator response in patients with asthma and COPD using 19F-MRI Source: Virtual Congress 2020 – New imaging techniques applied to old problems Year: 2020 Determinants of adherence to inhaled corticosteroids in children with asthma Source: Annual Congress 2010 - Managing asthma and allergic disease in children Year: 2010 Predictors for adherence to COPD exacerbation action plans Source: International Congress 2018 – Let’s interact and discuss the hot topics in pulmonary rehabilitation Year: 2018 Predictors of inhaled corticosteroid therapy in COPD alone compared to COPD with concomitant asthma managed in primary care Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Effect of QVA149 on lung function in the subgroup of patients with a history of exacerbations in the previous year and baseline ICS use from the SHINE study Source: International Congress 2014 – Asthma and COPD devices and treatments Year: 2014 Cardiovascular safety of long-term therapy with combination bronchodilator in patients with stable COPD Source: Eur Respir J 2004; 24: Suppl. 48, 290s Year: 2004 Individual and differential treatment responses to once-daily long acting bronchodilators, glycopirronium and indacaterol, and combination of both drugs in the patients with moderate or severe COPD Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 Comparison of protective effect of bronchodilators in COPD Source: International Congress 2015 – Safety of and interactions between current treatments for asthma and COPD Year: 2015 Effect of exacerbation history and ICS use on outcomes in COPD patients from the TIOSPIR™ trial Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 How the bronchodilatator in COPD patients works Source: Eur Respir J 2004; 24: Suppl. 48, 288s Year: 2004